Status:
WITHDRAWN
Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density
Lead Sponsor:
Cairo University
Conditions:
Diabetes Mellitus
Corneal Endothelial Cell Loss
Eligibility:
All Genders
40+ years
Phase:
PHASE4
Brief Summary
The prevalence of diabetes mellitus (DM) is rapidly growing worldwide. One major concern with diabetes mellitus is how it may affect vision in different ways; including the increased risk of developin...
Detailed Description
This is a prospective interventional randomized controlled cohort study to determine the safety and benefit of intracameral dexamethasone injection at the conclusion of phacoemulsification in diabetic...
Eligibility Criteria
Inclusion
- Age ≥ 40 years old
- Type 1 or Type 2 diabetes duration ≥ 10 years
- Visually significant cataract
Exclusion
- Dense central corneal opacities as dense nebulae and stromal dystrophies.
- Pre-operative endothelial cell count less than 1500 cell/mm2
- Fuchs dystrophy
- Associated ocular conditions that could affect endothelial cell count as glaucoma and uveitis
- Previous intraocular surgeries
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03361709
Start Date
January 1 2018
End Date
July 1 2018
Last Update
July 24 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.